Showing 11,401 - 11,420 results of 103,715 for search '(( 50 ((ns decrease) OR (mean decrease)) ) OR ( 5 ((we decrease) OR (a decrease)) ))', query time: 1.56s Refine Results
  1. 11401

    DataSheet1_Population pharmacokinetic study of pemetrexed in chinese primary advanced non-small cell lung carcinoma patients.docx by Peng Cao (107508)

    Published 2022
    “…Creatinine clearance (CrCl) was identified as a covariate to CL, and ERCC1 (rs3212986) and CYP3A5 (rs776746) gene polymorphisms as covariates to Q. …”
  2. 11402

    Basic characteristics of the studies included. by Renáta Kiss-Miki (20760127)

    Published 2025
    “…Odd ratios (OR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using a random-effects model. …”
  3. 11403

    List_of_studies_identified_31-JAN-2025. by Renáta Kiss-Miki (20760127)

    Published 2025
    “…Odd ratios (OR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using a random-effects model. …”
  4. 11404

    Data_extraction_table_31-JAN-2025. by Renáta Kiss-Miki (20760127)

    Published 2025
    “…Odd ratios (OR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using a random-effects model. …”
  5. 11405
  6. 11406
  7. 11407
  8. 11408
  9. 11409

    Table_5_Patient initiated follow-up in cancer patients: A systematic review.docx by Claire Newton (1773745)

    Published 2022
    “…</p>Objectives<p>To investigate the impact of PIFU on overall survival, progression free survival, patient satisfaction, psychological morbidity, specifically quality of life (QoL) and economic costs compared to hospital follow up (HFU), for any type of cancer.</p>Methods<p>We carried out a systematic review using five electronic databases: MEDLINE, CINAHL, EMBASE, PsycInfo and Cochrane Central Register of Controlled Trials. …”
  10. 11410
  11. 11411
  12. 11412
  13. 11413
  14. 11414
  15. 11415
  16. 11416
  17. 11417
  18. 11418
  19. 11419
  20. 11420